Brief: Oncocyte And Bio-Rad Partner On Global Launch Of Transplant Assay
April 11 (Reuters) - Oncocyte Corp OCX.O :
* ONCOCYTE AND BIO-RAD PARTNER ON GLOBAL LAUNCH OF
TRANSPLANT
ASSAY
* ONCOCYTE CORP - BIO-RAD HAS BEEN GRANTED AN OPTION FOR IVD
COMMERCIAL RIGHTS AT FDA CLEARANCE, SUBJECT TO MEETING SPECIFIC
OBJECTIVES
* ONCOCYTE CORP - BIO-RAD EXPECTS TO MAKE EQUITY INVESTMENT
IN
SUPPORT OF DEAL
* ONCOCYTE CORP - BIO-RAD AND ONCOCYTE WILL CO-MARKET ASSAY
INSIDE
US AND GERMANY, WITH ONCOCYTE ACTING AS COMMERCIAL LEAD
Source text for Eikon: ID:nGNX40yr7L
Further company coverage: OCX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Insight Molecular Diagnostics
See all newsBrief: Insight Molecular Diagnostics Enters Amendment No. 2 To Merger Agreement On Sept 15, 2026
Insight Molecular Diagnostics Inc reports results for the quarter ended June 30 - Earnings Summary
Insight Molecular Diagnostics Inc expected to post a loss of 24 cents a share - Earnings Preview
Insight Molecular Diagnostics Q1 loss narrows as costs drop
Brief: Insight Molecular Diagnostics Completes Key Milestones Advancing Graftassuredx Toward FDA Submission